IHL 0.00% 4.1¢ incannex healthcare limited

Look forward ole mate and not backward!We have some very...

  1. 1,958 Posts.
    lightbulb Created with Sketch. 4359
    Look forward ole mate and not backward!
    We have some very talented people in our corner.
    Dr Sud is World Renown for his experience and knowledge in this field.
    Fortunately for us, he is a brilliant businessman as well as a brilliant clinician

    Remember the company strategy
    Find already proven remedies from anecdotal evidence alone
    Test and prove those remedies that currently have unmet needs
    Must have TAM size of greater than $1bn
    Use the best in field professionals to give scientific rigor
    Develop and Protect the company with an economic moat via it's IP Strategy

    Now also the CEO has expanded on this by

    "There’s an increasing body of scientific literature that indicates that the best use of cannabinoids is to
    combine them with existing pharmaceutical drugs to produce better patient outcomes by either improving
    product safety, efficacy, or both. At Incannex, we are the first mover globally to formally develop
    sophisticated cannabinoid combination drugs as a business strategy.

    Upon proving synergy in our compounds in pre-clinical activities, we have been able to aggressively pursue
    patent protection over our three preferred unique combination compounds before competitors have been
    able to do so. This has opened significant economic potential over a broad range of indications."

    https://stocknessmonster.com/announcements/ihl.asx-3A585627/

    I agree it is all a bit unbelievable but these are the sort of results that we can also expect from other trials moving forward IMO
    Don't forget as @malkazoid pointed out we do also have some pre-clinical trial results coming soon for TBI / Concussion

    Good luck @Badvet73 cool.png

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.